Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Porter, Richard J
Robinson, Lucy J
Malhi, Gin S
and
Gallagher, Peter
2015.
The neurocognitive profile of mood disorders – a review of the evidence and methodological issues.
Bipolar Disorders,
Vol. 17,
Issue. S2,
p.
21.
Vázquez-Bourgon, Javier
Pérez-Iglesias, Rocío
Ortiz-García de la Foz, Víctor
Suárez Pinilla, Paula
Díaz Martínez, Álvaro
and
Crespo-Facorro, Benedicto
2018.
Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis.
Psychopharmacology,
Vol. 235,
Issue. 1,
p.
245.
Vázquez-Bourgon, Javier
Ibáñez Alario, Miguel
Mayoral-van Son, Jacqueline
Gómez Revuelta, Marcos
Ayesa Arriola, Rosa
Juncal Ruiz, María
Ortiz-García de la Foz, Víctor
and
Crespo Facorro, Benedicto
2020.
A 3-year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: A pragmatic clinical trial in first episode psychosis patients.
European Neuropsychopharmacology,
Vol. 39,
Issue. ,
p.
46.
Li, Jiqing
Si, Shucheng
Tang, Fang
Fu, Ping
and
Xue, Fuzhong
2021.
Effects of Antipsychotics on Triglyceride Trajectories and Its Implications in CVD: A Longitudinal Cohort Study.
SSRN Electronic Journal ,
Murru, Andrea
Anmella, Gerard
Giménez, Anna
and
Vieta, Eduard
2021.
Neurobiology of Bipolar Disorder.
p.
257.
Vázquez-Bourgon, Javier
Mayoral-van Son, Jaqueline
Gómez-Revuelta, Marcos
Juncal-Ruiz, María
Ortiz-García de la Foz, Víctor
Tordesillas-Gutiérrez, Diana
Ayesa-Arriola, Rosa
Bioque, Miquel
and
Crespo-Facorro, Benedicto
2021.
Treatment Discontinuation Impact on Long-Term (10-Year) Weight Gain and Lipid Metabolism in First-Episode Psychosis: Results From the PAFIP-10 Cohort.
International Journal of Neuropsychopharmacology,
Vol. 24,
Issue. 1,
p.
1.
Garrido-Torres, Nathalia
Ruiz-Veguilla, Miguel
Alameda, Luis
Canal-Rivero, Manuel
Ruiz, María Juncal
Gómez-Revuelta, Marcos
Ayesa-Arriola, Rosa
Rubio-García, Ana
Crespo-Facorro, Benedicto
and
Vázquez-Bourgon, Javier
2022.
Prevalence of metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: Baseline results from the PAFIP cohort.
Schizophrenia Research,
Vol. 246,
Issue. ,
p.
277.
Li, Jiqing
Wang, Fabing
Xue, Ruimei
Si, Shucheng
Tang, Fang
and
Xue, Fuzhong
2022.
Effects of antipsychotics on triglyceride trajectories and its implications in CVD: A longitudinal cohort study.
eBioMedicine,
Vol. 81,
Issue. ,
p.
104123.
Berge, Jonas
Abri, Paul
Andell, Pontus
Movahed, Pouya
and
Ragazan, Dragos C.
2022.
Associations between off-label low-dose olanzapine or quetiapine and cardiometabolic mortality.
Journal of Psychiatric Research,
Vol. 149,
Issue. ,
p.
352.
Vázquez-Bourgon, J.
Gómez-Revuelta, M.
Mayoral-van Son, J.
Labad, J.
Ortiz-García de la Foz, V.
Setién-Suero, E.
Ayesa-Arriola, R.
Tordesillas-Gutiérrez, D.
Juncal-Ruiz, M.
and
Crespo-Facorro, B.
2022.
Pattern of long-term weight and metabolic changes after a first episode of psychosis: Results from a 10-year prospective follow-up of the PAFIP program for early intervention in psychosis cohort.
European Psychiatry,
Vol. 65,
Issue. 1,
Gallagher, Peter
and
Young, Allan
2024.
Clinical Textbook of Mood Disorders.
p.
222.
Al-kayed, Jarrah
and
Okoli, Chizimuzo C.
2024.
General Factors That Reduce Cardiovascular Risk in People With Schizophrenia.
Journal of Cardiovascular Nursing,
Vol. 39,
Issue. 6,
p.
E198.
Comments
No Comments have been published for this article.